1. Home
  2. GNFT vs IPI Comparison

GNFT vs IPI Comparison

Compare GNFT & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • IPI
  • Stock Information
  • Founded
  • GNFT 1999
  • IPI 2000
  • Country
  • GNFT France
  • IPI United States
  • Employees
  • GNFT N/A
  • IPI N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • GNFT Health Care
  • IPI Industrials
  • Exchange
  • GNFT Nasdaq
  • IPI Nasdaq
  • Market Cap
  • GNFT 296.4M
  • IPI 356.5M
  • IPO Year
  • GNFT 2019
  • IPI 2008
  • Fundamental
  • Price
  • GNFT $3.82
  • IPI $25.16
  • Analyst Decision
  • GNFT Strong Buy
  • IPI Sell
  • Analyst Count
  • GNFT 1
  • IPI 2
  • Target Price
  • GNFT $13.00
  • IPI $21.00
  • AVG Volume (30 Days)
  • GNFT 6.7K
  • IPI 120.0K
  • Earning Date
  • GNFT 09-19-2024
  • IPI 11-04-2024
  • Dividend Yield
  • GNFT N/A
  • IPI N/A
  • EPS Growth
  • GNFT N/A
  • IPI N/A
  • EPS
  • GNFT 0.47
  • IPI N/A
  • Revenue
  • GNFT $86,225,222.00
  • IPI $206,359,000.00
  • Revenue This Year
  • GNFT $155.44
  • IPI N/A
  • Revenue Next Year
  • GNFT N/A
  • IPI $3.40
  • P/E Ratio
  • GNFT $7.73
  • IPI N/A
  • Revenue Growth
  • GNFT 175.45
  • IPI N/A
  • 52 Week Low
  • GNFT $3.31
  • IPI $17.52
  • 52 Week High
  • GNFT $6.42
  • IPI $29.75
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 26.50
  • IPI 40.18
  • Support Level
  • GNFT $3.73
  • IPI $24.72
  • Resistance Level
  • GNFT $4.06
  • IPI $25.94
  • Average True Range (ATR)
  • GNFT 0.12
  • IPI 1.06
  • MACD
  • GNFT 0.01
  • IPI -0.32
  • Stochastic Oscillator
  • GNFT 12.49
  • IPI 10.28

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: